Nasdaq Determines That TransCode Therapeutics Has Regained Compliance with Continued Listing Requirements
Hand-out
Press Releases
TransCode Therapeutics, Inc.  
January 7, 2025

Nasdaq Determines That TransCode Therapeutics Has Regained Compliance with Continued Listing Requirements

TransCode shares to remain listed on Nasdaq

avatar profile Olean Times Herald

Olean Times Herald


Local & Social